Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
08/08/202406:18Alliance NewsAlliance NewsTOP NEWS: UK CMA investigates Amazon's links to AI firm AnthropicLSE:0R1OAmazon.com Inc
08/08/202406:18Edgar (US Regulatory)Form 8-K - Current reportNYSE:TPVGTriplePoint Venture Growth BDC Corp
08/08/202406:17Alliance NewsAlliance NewsTOP NEWS: Chipmaker SMIC reports second quarter plunge in profit
08/08/202406:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMUXImmunic Inc
08/08/202406:15PR Newswire (US)Converge Reports Second Quarter 2024 ResultsTSX:CTSConverge Technology Solutions Corp
08/08/202406:15PR Newswire (US)Caldwell Guides Quick Quack on a Robust Patent Portfolio During $850 Million Investment Deal Made by a Leading Global Investment Firm
08/08/202406:10CointelegraphImmutable to shut down NFT marketplaceCOIN:BTCUSDBitcoin
08/08/202406:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:KCKingsoft Cloud Holdings Ltd
08/08/202406:07PR Newswire (Canada)Charlotte's Web Reports 2024 Second Quarter Financial ResultsTSX:CWEBCharlottes Web Holdings Inc
08/08/202406:05Alliance NewsAlliance NewsIAG's British Airways axes one of its "most important routes"LSE:IAGInternational Consolidated Airlines Group S.a.
08/08/202406:05GlobeNewswire Inc.Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:HOWLWerewolf Therapeutics Inc
08/08/202406:05GlobeNewswire Inc.Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:CLSDClearside Biomedical Inc
08/08/202406:05PR Newswire (US)REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:RGNXREGENXBIO Inc
08/08/202406:05GlobeNewswire Inc.Axogen, Inc. Announces New Leadership AppointmentsNASDAQ:AXGNAxogen Inc
08/08/202406:03GlobeNewswire Inc.Howard Hughes Holdings Forms Special Committee to Evaluate Potential Take-PrivateNYSE:HHHHoward Hughes Holdings Inc
08/08/202406:03PR Newswire (US)Get Smart: C & C Heating & Air Conditioning says smart homes will improve customer service in the HVAC industry
08/08/202406:01GlobeNewswire Inc.Onex Appoints Sara Wechter to Board of DirectorsTSX:ONEXOnex Corporation
08/08/202406:01GlobeNewswire Inc.Xometry Reports Second Quarter 2024 ResultsNASDAQ:XMTRXometry Inc
08/08/202406:00GlobeNewswire Inc.Synlogic Reports Second Quarter 2024 Financial ResultsNASDAQ:SYBXSynlogic Inc
08/08/202406:00GlobeNewswire Inc.Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
08/08/202406:00GlobeNewswire Inc.Onex Reports Second Quarter 2024 ResultsTSX:ONEXOnex Corporation
08/08/202406:00GlobeNewswire Inc.BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024AMEX:PHGEBiomX Inc
08/08/202406:00NEWSBTC3 Reasons Why Ethereum Is Struggling Today: Will ETH Break $2,000?COIN:ETHUSDEthereum
08/08/202406:00InvestorsHub NewsWireMaybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing AgreementUSOTC:AHROAuthentic Holdings Inc (PK)
08/08/202406:00GlobeNewswire Inc.Mikra Joins AcousticSheep for SleepPhones® x Serenity GiveawayM5B0.F
08/08/202406:00GlobeNewswire Inc.Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024NASDAQ:BPTHBio Path Holdings Inc
08/08/202406:00GlobeNewswire Inc.Oxford Biomedica – Half Year Trading Update and Notice of Interim ResultsLSE:OXBOxford Biomedica Plc
08/08/202406:00GlobeNewswire Inc.ECARX Announces Second Quarter 2024 Unaudited Financial ResultsNASDAQ:ECXECARX Holdings Inc
08/08/202406:00GlobeNewswire Inc.Immunocore reports second quarter financial results and provides a business updateNASDAQ:IMCRImmunocore Holdings PLC
08/08/202406:00GlobeNewswire Inc.Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial ResultsNASDAQ:VERVVerve Therapeutics Inc